LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 59.85 | 27.76 | 7483 | 6062 | 1.2343 | 1.0549 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 61.56 | 27.76 | 483 | 6217 | 0.0777 | 0.4418 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 61.56 | 27.76 | 6737 | 6217 | 1.0836 | 1.0207 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 61.56 | 27.76 | 818 | 6217 | 0.1316 | 0.5424 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 61.56 | 27.76 | 7906 | 6217 | 1.2716 | 1.0625 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.26 | 27.76 | 488 | 6465 | 0.0755 | 0.4399 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.26 | 27.76 | 7102 | 6465 | 1.0984 | 1.0240 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.26 | 27.76 | 934 | 6465 | 0.1445 | 0.5638 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.26 | 27.76 | 8329 | 6465 | 1.2882 | 1.0655 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 64.97 | 27.76 | 475 | 6656 | 0.0714 | 0.4322 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 64.97 | 27.76 | 7380 | 6656 | 1.1086 | 1.0263 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 64.97 | 27.76 | 833 | 6656 | 0.1251 | 0.5377 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 64.97 | 27.76 | 8687 | 6656 | 1.3050 | 1.0685 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 66.67 | 27.76 | 516 | 6695 | 0.0771 | 0.4467 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 66.67 | 27.76 | 7687 | 6695 | 1.1480 | 1.0352 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 66.67 | 27.76 | 998 | 6695 | 0.1491 | 0.5725 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 66.67 | 27.76 | 9058 | 6695 | 1.3528 | 1.0778 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 68.37 | 27.76 | 513 | 6879 | 0.0746 | 0.4430 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 68.37 | 27.76 | 7940 | 6879 | 1.1542 | 1.0364 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 68.37 | 27.76 | 1027 | 6879 | 0.1493 | 0.5746 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 68.37 | 27.76 | 9401 | 6879 | 1.3666 | 1.0801 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.08 | 27.76 | 533 | 6849 | 0.0778 | 0.4504 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.08 | 27.76 | 8307 | 6849 | 1.2128 | 1.0491 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.08 | 27.76 | 1121 | 6849 | 0.1637 | 0.5926 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.08 | 27.76 | 9698 | 6849 | 1.4158 | 1.0895 | MN20160318_Q01 | G18 |